Miss Loren Waters
Publication
2025
- Baldwin, A. et al. 2025. Tetrahydropyrazolopyridinones as a novel class of potent and highly selective LIMK inhibitors. Journal of Medicinal Chemistry 68 (16), pp.17427-17456. (10.1021/acs.jmedchem.5c00974)
- Baldwin, A. G. et al. 2025. Discovery of MDI-114215: A potent and selective LIMK inhibitor to treat fragile X syndrome. Journal of Medicinal Chemistry 68 (1), pp.719-752. (10.1021/acs.jmedchem.4c02694)
- Fdel, A. M. et al. 2025. Oxidative stress-responsive 1 kinase catalytic activity promotes triple negative breast cancer oncogenic potential. ACS pharmacology & translational science (10.1021/acsptsci.4c00603)
2022
- Collins, R. et al. 2022. Comparative analysis of small-molecule limk1/2 inhibitors: chemical synthesis, biochemistry, and cellular activity. Journal of Medicinal Chemistry (10.1021/acs.jmedchem.2c00751)
Articles
- Baldwin, A. et al. 2025. Tetrahydropyrazolopyridinones as a novel class of potent and highly selective LIMK inhibitors. Journal of Medicinal Chemistry 68 (16), pp.17427-17456. (10.1021/acs.jmedchem.5c00974)
- Baldwin, A. G. et al. 2025. Discovery of MDI-114215: A potent and selective LIMK inhibitor to treat fragile X syndrome. Journal of Medicinal Chemistry 68 (1), pp.719-752. (10.1021/acs.jmedchem.4c02694)
- Collins, R. et al. 2022. Comparative analysis of small-molecule limk1/2 inhibitors: chemical synthesis, biochemistry, and cellular activity. Journal of Medicinal Chemistry (10.1021/acs.jmedchem.2c00751)
- Fdel, A. M. et al. 2025. Oxidative stress-responsive 1 kinase catalytic activity promotes triple negative breast cancer oncogenic potential. ACS pharmacology & translational science (10.1021/acsptsci.4c00603)